Application no. and date | 20720419.9 (espacenet) (Federated) (European Patent Register), 20200417 | Patent/reg. no. and date | DK/EP 3965735, 20230830 | Publication date | 20220316 | Priority no. and date | GB 201906473, 20190508 | EP pub. no. and date |
EP 3965735 20220316 | Effective date | | Applicant/owner | Alkaloid AD Skopje, Blvd. Aleksandar Makedonski 12
1000 Skopje, MK | Applicant ref. no. | | Inventor | KRSTESKA, Ljiljana, Blvd. Jane Sandanski 36/4-6
1000 Skopje, MK, KAZANDZIEVSKA, Elena, ul. Zija Mersovski 4
1250 Debar, MK, WILLIS, Andrew, 21 Maryport Street
Usk NP15 1AB, GB | Representative | | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61K 47/02 (2006.01) , A61K 9/08 (2006.01) , A61P 1/00 (2006.01) , A61P 1/04 (2006.01) , A61P 25/20 (2006.01) | Title | PHARMACEUTICAL FORMULATION | Int. application no. | EP2020060869 | Int. publication no. | WO2020224936 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|